Mr. An Liu is General Manager, NAMSA
China. In 2012, he led the efforts and established NAMSA China WFOE. Now he is responsible for NAMSA’s business in China and Asia Pacific countries.
Mr. An Liu also provides consultation to many medical device manufacturers on US FDA and China FDA regulatory issues, including biological safety evaluation, preclinical studies and clinical trials. He has more than 10 years of experiences in medical device clinical trial, biostatistics, clinical data management, and regulatory.
Before current position Mr. An Liu was Director of Biostatistics and Data Management at NAMSA, Statistics Manager at Medtronic, Statistician at 3M, and Statistician at the US Veteran Affairs Medical Center. Mr. An Liu served as an adjunct faculty for St. Cloud State University and Metropolitan State University in Minnesota USA. He had a M.S. degree in Biostatistics from University of Minnesota, USA.